Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Business
Joe Middleton and agencies

GSK shares surge as US judge dismisses Zantac cancer claims

GlaxoSmithKline headquarters britain
The share price of the British pharmaceutical company has been significantly affected by the ongoing legislation surrounding the drug. Photograph: Ben Stansall/AFP/Getty Images

Shares in drug firms GlaxoSmithKline and Sanofi surged after a US judge dismissed thousands of lawsuits claiming that the heartburn drug Zantac caused cancer.

GSK’s shares jumped as much as 14% in early trading, while Sanofi’s stock jumped nearly 6% in mid-morning trading.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.